On September 27, 2019 Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology, reported that the company plans to present at the following conferences (Press release, Iovance Biotherapeutics, SEP 27, 2019, View Source [SID1234539886]):
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
EPPICon 2019 Annual Conference in Santa Clara, Calif., Sept. 28, 2019
Location: Santa Clara Convention Center
Date/Time: Saturday, Sept. 28, at 11:10 a.m. PDT
Cell & Gene Meeting on the Mesa in Carlsbad, Calif., Oct. 2-4, 2019
Location: Park Hyatt Aviara Resort
Date/Time: Thursday, Oct. 3, at 5:30 p.m. PDT
2019 Cantor Global Healthcare Conference in New York, Oct. 2-4, 2019
Location: InterContinental New York Barclay
Date/Time: Thursday, Oct. 3, at 3:35 p.m. EDT
Live and archived webcasts of the Cell & Gene Meeting on the Mesa and 2019 Cantor Global Healthcare Conference presentations will be available in the Investors section of the Iovance website at View Source